Keywords: novartis, files, glivec, gist, japan, switzerland, filed

Novartis files Glivec for GIST in Japan

Article | 03 February 2003

Print This

Switzerland's Novartis has filed for approval to market Glivec(imatinib) in the treatment of gastrointestinal stromal tumors in Japan. The ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in